Literature DB >> 11975074

[Basic principles and concepts of enteral nutrition of ENT patients].

F Waldfahrer1, H Iro.   

Abstract

Patients suffering from head and neck cancer often show malnutrition even at the time of diagnosis. Therapeutic measures as surgery, radiation and antineoplastic chemotherapy additionally decrease the nutritional status. Therefore, an early supportive intervention is necessary in accordance to prognosis and quality of life. For many reasons, enteral nutrition has advantages to total parenteral nutrition. Percutaneous endoscopically guided gastrostomy (PEG) is the method of choice, for the application of enteral nutrition in most cases; special situations can be covered by using nasogastral feeding tubes, jejunostomy techniques, open surgical approach or radiologically guided gastrostomy. The industry provides a lot of different products suitable for nearly all patients. Furthermore, PEG facilitates the application of pharmacological agents, e.g. analgetics. However, the patient must be integrated in a network of professional care to ensure a safe nutrition therapy also in an outpatient setting.

Entities:  

Mesh:

Year:  2002        PMID: 11975074     DOI: 10.1007/s00106-001-0613-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  3 in total

Review 1.  [Coincidental squamous cell cancers of the esophagus, head, and neck: risk and screening].

Authors:  H Scherübl; J Steinberg; C Schwertner; P Mir-Salim; U Stölzel; E-M de Villiers
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

Review 2.  Prevention of percutaneous endoscopic gastrostomy stoma metastases in patients with active oropharyngeal malignancy.

Authors:  D Maccabee; B C Sheppard
Journal:  Surg Endosc       Date:  2003-07-21       Impact factor: 4.584

3.  Reconstructive and rehabilitating methods in patients with dysphagia and nutritional disturbances.

Authors:  Christiane Motsch
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.